Refine by MP, party, committee, province, or result type.
Health committee Madam Chair, the minister mentioned in her opening comments that the entire portfolio, all of the operations of the portfolio in all the areas we've funded, was looked at. I can break down the reductions that are outlined in four categories. The first, I would say, is administr
November 20th, 2012Committee meeting
Glenda Yeates
Health committee I would say by category, the first category is that we asked some of our partners, our pan-Canadian organizations, to take some administrative reductions. For example, very good work is done by CIHI, by the Canadian Partnership Against Cancer, by the Mental Health Commission. We
November 20th, 2012Committee meeting
Glenda Yeates
Health committee No, all of the front line delivery services are being protected, so no community services for maternal and child health are being reduced.
November 20th, 2012Committee meeting
Glenda Yeates
Public Accounts committee We do intend to take that step to make sure. Right now we have a plan, and as the committee has requested, we will be even more specific about the steps in this plan. But we will broaden our information so that Canadians have information on conditions and rejections, for example.
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee Yes, we do, but I'll ask my colleague to speak to the specifics.
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee In rough figures, I'd say 10,000.
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee It's in the neighbourhood of $3.7 billion.
March 29th, 2012Committee meeting
Glenda Yeates
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee I wouldn't have that number with me. I'll just give an example the committee might be aware of. We are often the third party in a significant number of tobacco litigations, but there would be a number of others.
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee We are very committed to making clinical trial information more transparent, and we are currently in consultation about the best way of doing that. As the clinical trial sites become multinational, the question of whether we should build a Canadian-only site, or whether we should
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee When I mentioned that we are doing consultations and are exploring this, that is precisely the kind of thing we are exploring. We want to build something here. We want to go down the path that is the most useful to Canadians.
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee We are, in fact, moving in that direction. That will be when we come back with our commitment here. We have been—
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee I think we are at the moment. Because of the significant increase in resources that's come to us at this time through the user fee proposal, we are busily staffing up, in a sense, to those levels. So at this time I think we're feeling that we are simply trying to work through tha
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee Thank you. It's a very important question. What we would try to reassure the committee and to communicate to the committee is that when we are trying to assess the time between getting some piece of information and putting out a communication.... If we assess this to be a real a
March 29th, 2012Committee meeting
Glenda Yeates
Public Accounts committee Thank you. It's a very important question in terms of the generic reviews. We have established the targets precisely so that we can monitor to see where we're falling short, as we are in generics. We've seen a significant increase in the volume. In some cases we've seen an inc
March 29th, 2012Committee meeting
Glenda Yeates